Delivery Order SPE2DB20D9329-SPE2DB24FZK19
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,677.28 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, with an ultimate completion date of January 25, 2022. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,605.50 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, with an ultimate completion date of August 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
- This federal contract award, with ID SPE2DB20D9135|SPE2DB22FD2ZZ, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,959.66 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialized pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,584.16 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialty pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,653.12 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a pharmaceutical product, with a completion date of January 12, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $79,354.56 firm fixed-price delivery order is for the provision of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialized biologic medication, to fulfill the recurring medical supply needs of military health facilities worldwide. The award is part of a larger $499,999,999 indefinite delivery contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,547.40 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, with an ultimate completion date of October 10, 2024. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $46,531.20 firm fixed-price delivery order is for the supply of Xolair 150 mg/1.2 ml powder vials, with an ultimate completion date of October 13, 2021. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- This federal contract award, identified as SPE2DB20D9329|SPE2DB24FZJ67, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,284.40 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a pharmaceutical product, with a performance period ending on March 5, 2024. This award is issued under a larger indefinite delivery contract (IDC) valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $37,137.60 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a pharmaceutical product, with a period of performance through April 18, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with the DLA valued at up to $4,999,999 through 2025, which enables...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB24FZK19Delivery Order
This federal contract award, with ID SPE2DB20D9329|SPE2DB24FZK19, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,737 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a pharmaceutical product, with a final completion date of May 16, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group provides both routine and critical medications through this vehicle, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 4/25/24 |